"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","25/38","481/2914",1.03417870100825e-11,5.76037536461597e-09,3.27671356845773e-09,"MAPK3/SUMO1/MAPK14/CTNNB1/SMAD3/CREB1/SRC/MAPK1/AKT1/RBL1/MEN1/ABL1/AR/ESR1/YAP1/EP300/RB1/PRKACA/PRKAA2/CDK2/BRCA1/HDAC1/STAT1/NOTCH1/PARP1",25
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","25/38","499/2914",2.41906730268655e-11,6.73710243798203e-09,3.83231188478237e-09,"MAPK3/SUMO1/MAPK14/CTNNB1/SMAD3/CREB1/SRC/MAPK1/AKT1/RBL1/MEN1/ABL1/AR/ESR1/YAP1/EP300/RB1/PRKACA/PRKAA2/CDK2/BRCA1/HDAC1/STAT1/NOTCH1/PARP1",25
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","7/38","19/2914",1.61671154506765e-09,3.00169443534226e-07,1.70747429847495e-07,"MAPK3/SRC/MAPK1/ABL1/AR/YAP1/RB1",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","10/38","62/2914",2.6768918599038e-09,3.72757191491604e-07,2.12038013113433e-07,"MAPK3/SRC/MAPK1/AKT1/ABL1/AR/ESR1/YAP1/RB1/STAT1",10
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/38","24/2914",1.05952445439128e-08,1.18031024219189e-06,6.71403917414263e-07,"MAPK3/SRC/MAPK1/ABL1/AR/YAP1/RB1",7
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","18/38","397/2914",4.44530773390519e-07,4.12672734630865e-05,2.34743443492186e-05,"MAPK3/MAPK14/CTNNB1/SMAD3/RPS6KA5/CREB1/SRC/MAPK1/AKT1/PIAS2/ABL1/ROCK2/EP300/RPS6KA4/PRKACA/KDM6A/CDK2/NOTCH1",18
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","14/38","249/2914",1.15412772873596e-06,9.18355921294186e-05,5.22394656164698e-05,"MAPK3/SUMO1/SRC/MAPK1/AKT1/RBL1/ABL1/EP300/RB1/PLK1/PRKACA/CDK2/BRCA1/HDAC1",14
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","12/38","191/2914",2.66930191636075e-06,0.000185850145926617,0.00010571840484534,"MAPK3/SRC/MAPK1/AKT1/RBL1/ABL1/EP300/RB1/PLK1/PRKACA/CDK2/HDAC1",12
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","10/38","130/2914",3.60013033749409e-06,0.00022280806644269,0.000126741430594821,"MAPK3/MAPK14/CTNNB1/SRC/MAPK1/MEN1/ABL1/AR/ROCK2/PLK1",10
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","9/38","107/2914",5.79821968992191e-06,0.00032296083672865,0.000183712013333315,"SUMO1/PIAS2/AR/ESR1/EP300/TOPORS/BRCA1/HDAC1/PARP1",9
"R-HSA-2990846","R-HSA-2990846","SUMOylation","9/38","109/2914",6.76866682520419e-06,0.00034274067469443,0.000194963513338417,"SUMO1/PIAS2/AR/ESR1/EP300/TOPORS/BRCA1/HDAC1/PARP1",9
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","5/38","24/2914",1.02074912081666e-05,0.000473797716912399,0.000269513583654223,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1",5
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","13/38","268/2914",1.66661729270287e-05,0.000714081409258075,0.000406195793606124,"MAPK3/CTNNB1/SMAD3/CREB1/SRC/MAPK1/AKT1/ESR1/EP300/AMER1/HDAC1/STAT1/NOTCH1",13
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","6/38","47/2914",2.37402082021632e-05,0.000944521140614637,0.000537278396154221,"MAPK3/CREB1/SRC/MAPK1/PRKACA/PRKAA2",6
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","6/38","49/2914",3.03347967620987e-05,0.00112538161963123,0.000640158494772747,"MAPK3/CREB1/SRC/MAPK1/PRKACA/PRKAA2",6
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/38","30/2914",3.23269405998198e-05,0.00112538161963123,0.000640158494772747,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","7/38","77/2914",4.46497243230192e-05,0.0013869766686474,0.000788963388949951,"SRC/AKT1/RBL1/ABL1/RB1/CDK2/HDAC1",7
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","5/38","32/2914",4.48215081430038e-05,0.0013869766686474,0.000788963388949951,"MAPK3/RPS6KA5/CREB1/SRC/MAPK1",5
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/38","53/2914",4.79412818930675e-05,0.00140543652707572,0.000799464036000738,"CTNNB1/SMAD3/SRC/YAP1/EP300/NOTCH1",6
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","8/38","108/2914",5.31619951468084e-05,0.00148056156483861,0.000842197923115227,"MAPK3/CREB1/SRC/MAPK1/AKT1/ESR1/EP300/HDAC1",8
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","5/38","36/2914",8.07803042869943e-05,0.00214260140418361,0.00121879055590904,"SMAD3/RBL1/MEN1/HDAC1/PARP1",5
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/38","60/2914",9.78070256475627e-05,0.00247629605844056,0.00140860835980461,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","4/38","20/2914",0.000102656394908673,0.00248607008539699,0.00141416818615609,"RPS6KA5/SRC/MAPK1/RPS6KA4",4
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/38","21/2914",0.0001256277396378,0.00287418286740114,0.00163494102445005,"MAPK3/MAPK14/RPS6KA5/MAPK1",4
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","6/38","63/2914",0.00012900282169664,0.00287418286740114,0.00163494102445005,"MAPK3/CREB1/SRC/MAPK1/AKT1/ESR1",6
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/38","64/2914",0.000140998603719331,0.00302062393352568,0.00171824209390764,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","4/38","22/2914",0.00015211267580925,0.00313802816391674,0.00178502594224499,"CTNNB1/MEN1/EP300/HDAC1",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/38","95/2914",0.000172979003388527,0.00344104660312177,0.00195739398571228,"MAPK14/AKT1/EP300/PRKAA2/CDK2/BRCA1/HDAC1",7
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/38","24/2914",0.000216861191364891,0.00402638945300813,0.00229035854739762,"SMAD3/RBL1/MEN1/HDAC1",4
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","4/38","24/2914",0.000216861191364891,0.00402638945300813,0.00229035854739762,"MAPK3/CREB1/MAPK1/AKT1",4
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/38","10/2914",0.000230641451834496,0.00405357763657604,0.00230582418711025,"MAPK3/MAPK14/MAPK1",3
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/38","70/2914",0.000232880582352663,0.00405357763657604,0.00230582418711025,"MAPK3/MAPK14/RPS6KA5/CREB1/SRC/MAPK1",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","13/38","347/2914",0.000257382497301426,0.00434430457566347,0.00247120037281433,"MAPK3/MAPK14/CTNNB1/RPS6KA5/CREB1/SRC/MAPK1/AKT1/ESR1/YAP1/ROCK2/PRKACA/STAT1",13
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","8/38","136/2914",0.000273079879232985,0.00447369096272861,0.00254480011297612,"MAPK3/CREB1/SRC/MAPK1/AKT1/ESR1/EP300/HDAC1",8
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/38","104/2914",0.000305304356734653,0.00485870076289147,0.00276380786096633,"SMAD3/CREB1/AKT1/EP300/HDAC1/STAT1/NOTCH1",7
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","6/38","77/2914",0.000393933924000945,0.00588627333719092,0.00334832897003584,"MAPK3/CREB1/SRC/MAPK1/PRKACA/PRKAA2",6
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","4/38","28/2914",0.000402498550440481,0.00588627333719092,0.00334832897003584,"SUMO1/PIAS2/AR/ESR1",4
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","6/38","78/2914",0.000422712627446386,0.00588627333719092,0.00334832897003584,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","6/38","78/2914",0.000422712627446386,0.00588627333719092,0.00334832897003584,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","6/38","78/2914",0.000422712627446386,0.00588627333719092,0.00334832897003584,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","10/38","228/2914",0.00047171299194484,0.00640839357349454,0.00364533018165332,"MAPK3/MAPK14/CTNNB1/SRC/MAPK1/MEN1/ABL1/AR/ROCK2/PLK1",10
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/38","53/2914",0.000523195954575837,0.0069385749213986,0.00394691685030894,"MAPK3/RPS6KA5/SRC/MAPK1/RPS6KA4",5
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","6/38","83/2914",0.000592262105115705,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","4/38","31/2914",0.000601409476542302,0.00737184670656354,0.00419337779207337,"CTNNB1/AKT1/MEN1/HDAC1",4
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","6/38","84/2914",0.00063176687653684,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","6/38","84/2914",0.00063176687653684,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/38","85/2914",0.000673296980918699,0.00737184670656354,0.00419337779207337,"MAPK14/CTNNB1/SRC/AKT1/ROCK2/PRKACA",6
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/38","14/2914",0.000674787566634184,0.00737184670656354,0.00419337779207337,"MAPK3/SRC/MAPK1",3
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/38","14/2914",0.000674787566634184,0.00737184670656354,0.00419337779207337,"AKT1/EP300/HDAC1",3
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","6/38","86/2914",0.000716923592204775,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","6/38","86/2914",0.000716923592204775,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","6/38","86/2914",0.000716923592204775,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","6/38","86/2914",0.000716923592204775,0.00737184670656354,0.00419337779207337,"SRC/ABL1/ESR1/YAP1/EP300/HDAC1",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","6/38","87/2914",0.0007627190784508,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","6/38","87/2914",0.0007627190784508,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","6/38","87/2914",0.0007627190784508,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","4/38","33/2914",0.000767624971240009,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK14/SRC/MAPK1",4
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","4/38","33/2914",0.000767624971240009,0.00737184670656354,0.00419337779207337,"MAPK3/MAPK1/RB1/PLK1",4
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","6/38","88/2914",0.000810756985622134,0.00757877235104085,0.00431108471636265,"MAPK3/CREB1/SRC/MAPK1/PRKACA/PRKAA2",6
"R-HSA-1643685","R-HSA-1643685","Disease","14/38","443/2914",0.000825574990144869,0.00757877235104085,0.00431108471636265,"MAPK3/CTNNB1/SMAD3/CREB1/SRC/MAPK1/AKT1/ESR1/EP300/PRKACA/AMER1/HDAC1/STAT1/NOTCH1",14
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","9/38","201/2914",0.000829991226954205,0.00757877235104085,0.00431108471636265,"MAPK3/CREB1/SRC/MAPK1/AKT1/ESR1/TRAF6/PRKACA/HDAC1",9
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/38","89/2914",0.000861112020675423,0.00773611928251953,0.00440058944351956,"MAPK3/MAPK14/RPS6KA5/CREB1/SRC/MAPK1",6
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","13/38","393/2914",0.00088664682328557,0.00783107752163629,0.00445460518569881,"SUMO1/SMAD3/FBXO22/PIAS2/MEN1/AR/ESR1/EP300/TRAF6/TOPORS/BRCA1/HDAC1/PARP1",13
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","6/38","90/2914",0.000913860033943194,0.00783107752163629,0.00445460518569881,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","6/38","90/2914",0.000913860033943194,0.00783107752163629,0.00445460518569881,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/38","60/2914",0.000931677576559303,0.00786279409308381,0.00447264673914434,"AKT1/RBL1/RB1/CDK2/HDAC1",5
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/38","16/2914",0.00101956944149445,0.00828916100899479,0.00471517993708293,"MAPK3/MAPK14/MAPK1",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/38","92/2914",0.00102684400290959,0.00828916100899479,0.00471517993708293,"MAPK14/CTNNB1/SRC/AKT1/ROCK2/PRKACA",6
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","6/38","92/2914",0.00102684400290959,0.00828916100899479,0.00471517993708293,"MAPK3/SRC/MAPK1/AKT1/ESR1/TRAF6",6
"R-HSA-422475","R-HSA-422475","Axon guidance","10/38","254/2914",0.00111396256194514,0.00886395924290635,0.00504214633301486,"MAPK3/MAPK14/RPS6KA5/CREB1/SRC/MAPK1/ABL1/ROCK2/RPS6KA4/PRKACA",10
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/38","63/2914",0.00116536568674794,0.00901539843775834,0.00512829052209252,"SMAD3/RBL1/MEN1/HDAC1/PARP1",5
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","5/38","63/2914",0.00116536568674794,0.00901539843775834,0.00512829052209252,"SUMO1/ABL1/CDK2/BRCA1/PARP1",5
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/38","37/2914",0.00119344481030118,0.00910614738818849,0.00517991186590709,"SUMO1/PIAS2/EP300/TOPORS",4
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/38","17/2914",0.00122693441323084,0.00923516848877806,0.005253303817674,"SMAD3/EP300/NOTCH1",3
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","4/38","38/2914",0.00132143483658491,0.00974396569511117,0.00554272639937345,"SUMO1/PIAS2/BRCA1/PARP1",4
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","8/38","172/2914",0.00132951776091284,0.00974396569511117,0.00554272639937345,"MAPK3/CREB1/SRC/MAPK1/AKT1/ESR1/TRAF6/HDAC1",8
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/38","18/2914",0.00145910873919705,0.0104195329196507,0.00592701390685982,"MAPK3/CREB1/MAPK1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/38","18/2914",0.00145910873919705,0.0104195329196507,0.00592701390685982,"EP300/STAT1/NOTCH1",3
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","6/38","99/2914",0.00150933280610321,0.0106417515569555,0.0060534200484619,"MAPK3/SRC/MAPK1/AKT1/ESR1/TRAF6",6
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/38","40/2914",0.00160575434990901,0.0109073801573088,0.00620451937512983,"SRC/RBL1/ABL1/RB1",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/38","40/2914",0.00160575434990901,0.0109073801573088,0.00620451937512983,"SRC/RBL1/ABL1/RB1",4
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/38","40/2914",0.00160575434990901,0.0109073801573088,0.00620451937512983,"SMAD3/AKT1/EP300/NOTCH1",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/38","19/2914",0.00171714813488525,0.0113863275134653,0.00647696226316364,"RBL1/CDK2/HDAC1",3
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","3/38","19/2914",0.00171714813488525,0.0113863275134653,0.00647696226316364,"RPS6KA5/EP300/PRKACA",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/38","20/2914",0.00200205844193994,0.0131193712018888,0.00746278131298974,"SMAD3/HDAC1/PARP1",3
"R-HSA-112316","R-HSA-112316","Neuronal System","6/38","105/2914",0.0020470849298037,0.0132584454174496,0.00754189184664522,"MAPK3/CREB1/SRC/MAPK1/PRKACA/PRKAA2",6
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","5/38","72/2914",0.00212973878600657,0.0136352241816742,0.00775621747837843,"RPS6KA5/SRC/EP300/TRAF6/PRKACA",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","6/38","108/2914",0.0023653083548942,0.014971326746319,0.00851624180410472,"CTNNB1/AKT1/MEN1/EP300/AMER1/HDAC1",6
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","11/38","332/2914",0.00248887391401885,0.0155764356191966,0.00886045000732908,"MAPK3/MAPK14/SMAD3/RPS6KA5/CREB1/MAPK1/AKT1/TRAF6/PRKACA/PTPN13/STAT1",11
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","6/38","110/2914",0.00259742016230209,0.0159090780063704,0.00904966924296983,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/38","22/2914",0.00265627334756274,0.0159090780063704,0.00904966924296983,"MAPK3/CREB1/MAPK1",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/38","22/2914",0.00265627334756274,0.0159090780063704,0.00904966924296983,"MAPK14/CTNNB1/ABL1",3
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","3/38","22/2914",0.00265627334756274,0.0159090780063704,0.00904966924296983,"CREB1/PRKACA/HDAC1",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","8/38","194/2914",0.00287986982223827,0.0170647605424119,0.00970706401448733,"MAPK14/AKT1/RBL1/EP300/PRKAA2/CDK2/BRCA1/HDAC1",8
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/38","23/2914",0.00302735151349634,0.0175649457605985,0.00999158778028944,"MAPK3/MAPK1/RB1",3
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","3/38","23/2914",0.00302735151349634,0.0175649457605985,0.00999158778028944,"SUMO1/PIAS2/HDAC1",3
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","5/38","80/2914",0.00339165771216347,0.0190986952293563,0.0108640409412005,"MAPK14/CREB1/PLK1/PRKACA/PRKAA2",5
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","4/38","49/2914",0.0034225552736562,0.0190986952293563,0.0108640409412005,"SMAD3/AKT1/EP300/HDAC1",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/38","24/2914",0.00342885013094368,0.0190986952293563,0.0108640409412005,"AKT1/EP300/NOTCH1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/38","24/2914",0.00342885013094368,0.0190986952293563,0.0108640409412005,"MAPK3/MAPK1/STAT1",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","5/38","81/2914",0.00358064506638466,0.0197467257621411,0.0112326645646877,"SUMO1/ABL1/CDK2/BRCA1/PARP1",5
"R-HSA-109582","R-HSA-109582","Hemostasis","10/38","298/2914",0.00374692949631297,0.0204611738181012,0.0116390689204355,"MAPK3/MAPK14/SRC/MAPK1/AKT1/ABL1/PRKACA/CDK2/PRKCH/HDAC1",10
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","3/38","25/2914",0.0038615441427004,0.0204845722617536,0.0116523788165696,"MAPK3/SRC/MAPK1",3
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/38","25/2914",0.0038615441427004,0.0204845722617536,0.0116523788165696,"MAPK3/MAPK1/ABL1",3
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/38","25/2914",0.0038615441427004,0.0204845722617536,0.0116523788165696,"SUMO1/ESR1/EP300",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/38","26/2914",0.00432616583726664,0.0227327770882785,0.0129312404867652,"CREB1/MAPK1/PRKACA",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/38","86/2914",0.00464145798928853,0.0237755497798708,0.0135244079821244,"SMAD3/RBL1/MEN1/HDAC1/PARP1",5
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","6/38","124/2914",0.00473743993837541,0.0237755497798708,0.0135244079821244,"SMAD3/AR/ESR1/EP300/TRAF6/BRCA1",6
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","3/38","27/2914",0.0048234059697045,0.0237755497798708,0.0135244079821244,"SRC/ESR1/YAP1",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/38","27/2914",0.0048234059697045,0.0237755497798708,0.0135244079821244,"PIAS2/EP300/KDM6A",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/38","27/2914",0.0048234059697045,0.0237755497798708,0.0135244079821244,"PIAS2/EP300/KDM6A",3
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/38","27/2914",0.0048234059697045,0.0237755497798708,0.0135244079821244,"MAPK3/SRC/MAPK1",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","3/38","27/2914",0.0048234059697045,0.0237755497798708,0.0135244079821244,"CREB1/EP300/CDK2",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","6/38","127/2914",0.00532924732674275,0.0259315702350349,0.0147508317882368,"MAPK3/MAPK14/RPS6KA5/CREB1/MAPK1/TRAF6",6
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/38","28/2914",0.00535391486001618,0.0259315702350349,0.0147508317882368,"MAPK3/SRC/MAPK1",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","4/38","56/2914",0.00555798291641057,0.026687900727937,0.0151810604159672,"MAPK14/PRKAA2/CDK2/BRCA1",4
"R-HSA-168249","R-HSA-168249","Innate Immune System","12/38","428/2914",0.00619367031334684,0.0294861056797794,0.0167727824050148,"MAPK3/MAPK14/CTNNB1/RPS6KA5/CREB1/SRC/MAPK1/ABL1/EP300/TRAF6/PRKACA/NLRX1",12
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","3/38","30/2914",0.00651714445495769,0.0305046173227852,0.0173521493227976,"MAPK3/SRC/MAPK1",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/38","30/2914",0.00651714445495769,0.0305046173227852,0.0173521493227976,"RBL1/EP300/CDK2",3
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","4/38","59/2914",0.00669723841999564,0.0308294363631204,0.0175369183507498,"SUMO1/ABL1/CDK2/BRCA1",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","4/38","59/2914",0.00669723841999564,0.0308294363631204,0.0175369183507498,"MAPK3/MAPK1/AKT1/HDAC1",4
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/38","10/2914",0.00697740560867865,0.0308445628891588,0.0175455228756247,"MAPK3/MAPK1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/38","10/2914",0.00697740560867865,0.0308445628891588,0.0175455228756247,"RBL1/HDAC1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/38","10/2914",0.00697740560867865,0.0308445628891588,0.0175455228756247,"SUMO1/TOPORS",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/38","10/2914",0.00697740560867865,0.0308445628891588,0.0175455228756247,"MAPK3/MAPK1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/38","10/2914",0.00697740560867865,0.0308445628891588,0.0175455228756247,"MAPK3/MAPK1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/38","32/2914",0.00782028883980249,0.0337666735175968,0.0192077269749535,"MAPK3/SRC/MAPK1",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/38","32/2914",0.00782028883980249,0.0337666735175968,0.0192077269749535,"MAPK3/SRC/MAPK1",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/38","32/2914",0.00782028883980249,0.0337666735175968,0.0192077269749535,"MAPK3/MAPK1/HDAC1",3
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","4/38","62/2914",0.00798252384201065,0.0339409601526712,0.0193068676291298,"MAPK3/SRC/MAPK1/ABL1",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/38","62/2914",0.00798252384201065,0.0339409601526712,0.0193068676291298,"ABL1/PRKACA/CDK2/HDAC1",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","5/38","99/2914",0.00842631758278772,0.0351579248189123,0.0199991219323304,"MAPK3/MAPK14/MAPK1/RB1/CDK2",5
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/38","11/2914",0.00845810040526796,0.0351579248189123,0.0199991219323304,"RBL1/HDAC1",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/38","11/2914",0.00845810040526796,0.0351579248189123,0.0199991219323304,"CREB1/EP300",2
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/38","187/2914",0.00921787339680876,0.037135478228448,0.0211240271128467,"MAPK3/MAPK14/MAPK1/AR/EP300/RB1/CDK2",7
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/38","34/2914",0.00926720192774556,0.037135478228448,0.0211240271128467,"CREB1/MAPK1/PRKACA",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/38","34/2914",0.00926720192774556,0.037135478228448,0.0211240271128467,"CREB1/MAPK1/PRKACA",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/38","34/2914",0.00926720192774556,0.037135478228448,0.0211240271128467,"MAPK3/SRC/MAPK1",3
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/38","34/2914",0.00926720192774556,0.037135478228448,0.0211240271128467,"SUMO1/ABL1/BRCA1",3
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/38","189/2914",0.00975393030574283,0.0373808880231222,0.0212636252385142,"MAPK3/MAPK14/MAPK1/AR/EP300/RB1/CDK2",7
"R-HSA-69275","R-HSA-69275","G2/M Transition","4/38","66/2914",0.0099362034241669,0.0373808880231222,0.0212636252385142,"EP300/PLK1/PRKACA/CDK2",4
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","3/38","35/2914",0.0100456251633806,0.0373808880231222,0.0212636252385142,"SUMO1/ABL1/BRCA1",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"MAPK3/MAPK1",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"MAPK3/MAPK1",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"MAPK3/MAPK1",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"EP300/NOTCH1",2
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"CREB1/PRKACA",2
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"PRKACA/HDAC1",2
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"PRKACA/HDAC1",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/38","12/2914",0.0100666664335159,0.0373808880231222,0.0212636252385142,"CREB1/HDAC1",2
"R-HSA-68886","R-HSA-68886","M Phase","5/38","105/2914",0.0107470049009614,0.039642925363149,0.0225503553516164,"MAPK3/MAPK1/RB1/PLK1/PRKACA",5
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","4/38","68/2914",0.0110205144161072,0.0403216640993686,0.0229364469317017,"EP300/PLK1/PRKACA/CDK2",4
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/38","37/2914",0.0117142249708234,0.0403216640993686,0.0229364469317017,"CTNNB1/AMER1/HDAC1",3
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/38","37/2914",0.0117142249708234,0.0403216640993686,0.0229364469317017,"MAPK3/SRC/MAPK1",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/38","37/2914",0.0117142249708234,0.0403216640993686,0.0229364469317017,"EP300/STAT1/NOTCH1",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"CREB1/PRKACA",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"MAPK3/MAPK1",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"MAPK14/SRC",2
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"SUMO1/TOPORS",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"CTNNB1/MEN1",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"EP300/BRCA1",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"EP300/NOTCH1",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/38","13/2914",0.0117996970344651,0.0403216640993686,0.0229364469317017,"CDK2/BRCA1",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","3/38","38/2914",0.0126050355537581,0.0425515442632926,0.0242048848592102,"MAPK14/CREB1/PRKAA2",3
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/38","38/2914",0.0126050355537581,0.0425515442632926,0.0242048848592102,"MAPK3/SRC/MAPK1",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","6/38","153/2914",0.0129725086095089,0.0435282367198582,0.0247604634842243,"MAPK3/MAPK14/SRC/MAPK1/AKT1/PRKCH",6
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/38","39/2914",0.0135338924625866,0.0437080096386631,0.0248627249385573,"AKT1/RB1/CDK2",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"CTNNB1/AMER1",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/38","14/2914",0.0136538486124369,0.0437080096386631,0.0248627249385573,"SUMO1/STAT1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/38","40/2914",0.014501038796047,0.0458924920988532,0.0261053389809219,"EP300/HDAC1/NOTCH1",3
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/38","40/2914",0.014501038796047,0.0458924920988532,0.0261053389809219,"AKT1/RB1/CDK2",3
"R-HSA-73894","R-HSA-73894","DNA Repair","6/38","157/2914",0.0146142877043648,0.0459895946402893,0.0261605744812002,"SUMO1/ABL1/EP300/CDK2/BRCA1/PARP1",6
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/38","41/2914",0.0155066896185551,0.0473021341220868,0.0269071952579574,"MAPK3/SRC/MAPK1",3
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","3/38","41/2914",0.0155066896185551,0.0473021341220868,0.0269071952579574,"CREB1/PRKACA/HDAC1",3
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/38","15/2914",0.0156258396381759,0.0473021341220868,0.0269071952579574,"EP300/HDAC1",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/38","15/2914",0.0156258396381759,0.0473021341220868,0.0269071952579574,"RBL1/EP300",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/38","15/2914",0.0156258396381759,0.0473021341220868,0.0269071952579574,"RBL1/HDAC1",2
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","2/38","15/2914",0.0156258396381759,0.0473021341220868,0.0269071952579574,"CTNNB1/SRC",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/38","15/2914",0.0156258396381759,0.0473021341220868,0.0269071952579574,"SMAD3/PTPN13",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/38","42/2914",0.0165510327817402,0.049036836486326,0.0278939578236495,"MAPK3/SRC/MAPK1",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/38","42/2914",0.0165510327817402,0.049036836486326,0.0278939578236495,"MAPK3/SRC/MAPK1",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/38","42/2914",0.0165510327817402,0.049036836486326,0.0278939578236495,"MAPK3/SRC/MAPK1",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/38","42/2914",0.0165510327817402,0.049036836486326,0.0278939578236495,"MAPK3/SRC/MAPK1",3
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/38","43/2914",0.0176342297286949,0.0511183132855658,0.0290779784540401,"MAPK3/MAPK1/ABL1",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/38","16/2914",0.0177124496662732,0.0511183132855658,0.0290779784540401,"MAPK3/MAPK1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/38","16/2914",0.0177124496662732,0.0511183132855658,0.0290779784540401,"CTNNB1/AMER1",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/38","16/2914",0.0177124496662732,0.0511183132855658,0.0290779784540401,"SUMO1/PIAS2",2
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","2/38","16/2914",0.0177124496662732,0.0511183132855658,0.0290779784540401,"SRC/EP300",2
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","3/38","44/2914",0.0187564162812451,0.0535760198392487,0.030476012419189,"SRC/ESR1/YAP1",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/38","44/2914",0.0187564162812451,0.0535760198392487,0.030476012419189,"MAPK3/MAPK14/MAPK1",3
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/38","17/2914",0.0199105183666789,0.05603111514985,0.0318725610131434,"SUMO1/PIAS2",2
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/38","17/2914",0.0199105183666789,0.05603111514985,0.0318725610131434,"MAPK14/SRC",2
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","3/38","45/2914",0.0199177034105391,0.05603111514985,0.0318725610131434,"MAPK3/MAPK1/CDK2",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/38","46/2914",0.0211181779912525,0.0591096740760184,0.0336237586636711,"MAPK3/SRC/MAPK1",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","6/38","172/2914",0.0220788124131561,0.0614894925706397,0.0349774870334736,"CTNNB1/AKT1/MEN1/EP300/AMER1/HDAC1",6
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/38","18/2914",0.0222169445701141,0.0615663588335999,0.0350212113935813,"PLK1/CDK2",2
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","3/38","48/2914",0.0236369209361267,0.0651770542644682,0.0370751078779267,"SUMO1/CDK2/BRCA1",3
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","2/38","19/2914",0.0246286853271999,0.0668272777223481,0.0380138157316957,"SRC/AKT1",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/38","19/2914",0.0246286853271999,0.0668272777223481,0.0380138157316957,"SMAD3/HDAC1",2
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","3/38","49/2914",0.0249552491315052,0.0668272777223481,0.0380138157316957,"MAPK3/MAPK1/AKT1",3
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/38","49/2914",0.0249552491315052,0.0668272777223481,0.0380138157316957,"MAPK3/MAPK1/EP300",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/38","49/2914",0.0249552491315052,0.0668272777223481,0.0380138157316957,"MAPK3/SRC/MAPK1",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/38","49/2914",0.0249552491315052,0.0668272777223481,0.0380138157316957,"ESR1/EP300/HDAC1",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/38","50/2914",0.0263128858390403,0.070125729245672,0.0398900963865582,"MAPK3/SRC/MAPK1",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/38","20/2914",0.0271427549811177,0.0704765441706678,0.0400896528307115,"MAPK14/SRC",2
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","2/38","20/2914",0.0271427549811177,0.0704765441706678,0.0400896528307115,"MAPK3/MAPK1",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/38","20/2914",0.0271427549811177,0.0704765441706678,0.0400896528307115,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/38","20/2914",0.0271427549811177,0.0704765441706678,0.0400896528307115,"MAPK3/HDAC1",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/38","20/2914",0.0271427549811177,0.0704765441706678,0.0400896528307115,"EP300/HDAC1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","3/38","51/2914",0.0277098082107293,0.0704765441706678,0.0400896528307115,"EP300/HDAC1/NOTCH1",3
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","3/38","51/2914",0.0277098082107293,0.0704765441706678,0.0400896528307115,"EP300/HDAC1/NOTCH1",3
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","3/38","51/2914",0.0277098082107293,0.0704765441706678,0.0400896528307115,"EP300/HDAC1/NOTCH1",3
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","3/38","51/2914",0.0277098082107293,0.0704765441706678,0.0400896528307115,"EP300/HDAC1/NOTCH1",3
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","3/38","51/2914",0.0277098082107293,0.0704765441706678,0.0400896528307115,"EP300/HDAC1/NOTCH1",3
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","2/38","21/2914",0.0297562242536223,0.0749964566030208,0.042660745417196,"SRC/ROCK2",2
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/38","21/2914",0.0297562242536223,0.0749964566030208,0.042660745417196,"MAPK14/TRAF6",2
"R-HSA-1500620","R-HSA-1500620","Meiosis","2/38","22/2914",0.0324662193442282,0.0814580368231312,0.0463363301214448,"CDK2/BRCA1",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/38","55/2914",0.0336892143974346,0.0837718411579067,0.0476525072068977,"MAPK3/SRC/MAPK1",3
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/38","55/2914",0.0336892143974346,0.0837718411579067,0.0476525072068977,"SUMO1/EP300/PARP1",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/38","23/2914",0.0352699210423932,0.086163798336022,0.0490131405067422,"MAPK3/MAPK1",2
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/38","23/2914",0.0352699210423932,0.086163798336022,0.0490131405067422,"EP300/NOTCH1",2
"R-HSA-392518","R-HSA-392518","Signal amplification","2/38","23/2914",0.0352699210423932,0.086163798336022,0.0490131405067422,"MAPK14/SRC",2
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","2/38","23/2914",0.0352699210423932,0.086163798336022,0.0490131405067422,"ABL1/BRCA1",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/38","97/2914",0.0358297963235504,0.0871493299223475,0.0495737471541654,"CREB1/SRC/AKT1/ESR1",4
"R-HSA-1474165","R-HSA-1474165","Reproduction","2/38","24/2914",0.0381645638525249,0.0916278537321396,0.0521212963684664,"CDK2/BRCA1",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/38","24/2914",0.0381645638525249,0.0916278537321396,0.0521212963684664,"RB1/CDK2",2
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","2/38","24/2914",0.0381645638525249,0.0916278537321396,0.0521212963684664,"CREB1/AKT1",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/38","59/2914",0.040290455171038,0.095100088665243,0.0540964314244319,"CREB1/MAPK1/PRKACA",3
"R-HSA-109581","R-HSA-109581","Apoptosis","4/38","101/2914",0.0406893245891673,0.095100088665243,0.0540964314244319,"MAPK3/CTNNB1/MAPK1/AKT1",4
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"CREB1/PRKACA",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"CREB1/PRKACA",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"SRC/AKT1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"PLK1/PRKACA",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"PLK1/PRKACA",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"CTNNB1/AKT1",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/38","25/2914",0.0411474351316402,0.095100088665243,0.0540964314244319,"SRC/AKT1",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","4/38","103/2914",0.0432550122657171,0.0995580240991918,0.0566322692126178,"MAPK3/CTNNB1/MAPK1/AKT1",4
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/38","26/2914",0.0442158742395046,0.0997094815846318,0.0567184238060553,"AKT1/PRKAA2",2
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/38","26/2914",0.0442158742395046,0.0997094815846318,0.0567184238060553,"HDAC1/NOTCH1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/38","26/2914",0.0442158742395046,0.0997094815846318,0.0567184238060553,"PLK1/PRKACA",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/38","26/2914",0.0442158742395046,0.0997094815846318,0.0567184238060553,"PLK1/PRKACA",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/38","26/2914",0.0442158742395046,0.0997094815846318,0.0567184238060553,"ESR1/STAT1",2
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/38","62/2914",0.0456436087016896,0.102514072769521,0.058313778519561,"SUMO1/CDK2/BRCA1",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"AKT1/PRKAA2",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"PLK1/PRKACA",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"PLK1/PRKACA",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"ESR1/TRAF6",2
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"SUMO1/BRCA1",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/38","27/2914",0.0473672717010886,0.103872324163411,0.0590864019147438,"ABL1/YAP1",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","3/38","64/2914",0.0494008989194574,0.107485549602101,0.0611417375606772,"EP300/HDAC1/NOTCH1",3
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","3/38","64/2914",0.0494008989194574,0.107485549602101,0.0611417375606772,"SRC/ABL1/PRKACA",3
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/38","28/2914",0.0505990683811711,0.109239073985707,0.0621392067838943,"PLK1/PRKACA",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/38","28/2914",0.0505990683811711,0.109239073985707,0.0621392067838943,"EP300/TRAF6",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/38","66/2914",0.053306786350634,0.11373930436253,0.0646991034926232,"EP300/TRAF6/NLRX1",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/38","29/2914",0.0539087546709299,0.11373930436253,0.0646991034926232,"SRC/STAT1",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/38","29/2914",0.0539087546709299,0.11373930436253,0.0646991034926232,"EP300/NOTCH1",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/38","29/2914",0.0539087546709299,0.11373930436253,0.0646991034926232,"CREB1/EP300",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/38","29/2914",0.0539087546709299,0.11373930436253,0.0646991034926232,"AKT1/CDK2",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/38","29/2914",0.0539087546709299,0.11373930436253,0.0646991034926232,"AKT1/CDK2",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/38","30/2914",0.0572938696863565,0.11907718438545,0.0677354861570829,"CREB1/PRKACA",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/38","30/2914",0.0572938696863565,0.11907718438545,0.0677354861570829,"MAPK3/MAPK1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/38","30/2914",0.0572938696863565,0.11907718438545,0.0677354861570829,"CTNNB1/AMER1",2
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","2/38","30/2914",0.0572938696863565,0.11907718438545,0.0677354861570829,"SUMO1/PARP1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/38","114/2914",0.0589879888399103,0.122142415553272,0.069479102488018,"SUMO1/PLK1/CDK2/BRCA1",4
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","2/38","31/2914",0.0607520004783366,0.124407589214829,0.0707676166562667,"SRC/AKT1",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/38","31/2914",0.0607520004783366,0.124407589214829,0.0707676166562667,"MAPK14/AKT1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/38","31/2914",0.0607520004783366,0.124407589214829,0.0707676166562667,"CTNNB1/AMER1",2
"R-HSA-69242","R-HSA-69242","S Phase","3/38","71/2914",0.0637072635999772,0.129981486539148,0.0739382546504459,"AKT1/RB1/CDK2",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/38","32/2914",0.0642807812542388,0.130197800576767,0.0740613020383766,"MAPK3/MAPK1",2
"R-HSA-8853659","R-HSA-8853659","RET signaling","2/38","32/2914",0.0642807812542388,0.130197800576767,0.0740613020383766,"SRC/PRKACA",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/38","119/2914",0.0670404321952334,0.135295364973714,0.0769609843278614,"EP300/PRKACA/PRKAA2/PTPN13",4
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/38","33/2914",0.0678778926108569,0.135999950303048,0.0773617784016203,"MAPK14/TRAF6",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/38","33/2914",0.0678778926108569,0.135999950303048,0.0773617784016203,"SRC/AKT1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/38","34/2914",0.0715410607785513,0.140806964147184,0.080096184840409,"MAPK3/STAT1",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/38","34/2914",0.0715410607785513,0.140806964147184,0.080096184840409,"PLK1/CDK2",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/38","34/2914",0.0715410607785513,0.140806964147184,0.080096184840409,"CTNNB1/EP300",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/38","34/2914",0.0715410607785513,0.140806964147184,0.080096184840409,"SRC/ROCK2",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/38","34/2914",0.0715410607785513,0.140806964147184,0.080096184840409,"MAPK3/MAPK1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/38","35/2914",0.0752680568764405,0.146588488392228,0.0833849286706241,"MAPK3/STAT1",2
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/38","35/2914",0.0752680568764405,0.146588488392228,0.0833849286706241,"MAPK14/SRC",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/38","35/2914",0.0752680568764405,0.146588488392228,0.0833849286706241,"AKT1/PRKAA2",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/38","37/2914",0.0829048373903571,0.1603402584251,0.0912074417196546,"EP300/HDAC1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/38","37/2914",0.0829048373903571,0.1603402584251,0.0912074417196546,"PLK1/PRKACA",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/38","80/2914",0.0846098755347563,0.163071628625811,0.0927611456418199,"SMAD3/AR/TRAF6",3
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","3/38","82/2914",0.0896149522255398,0.172122511688364,0.0979096211248185,"SMAD3/TRAF6/PTPN13",3
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/38","40/2914",0.0947854961262788,0.180806579939511,0.102849438839257,"PLK1/CDK2",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/38","40/2914",0.0947854961262788,0.180806579939511,0.102849438839257,"PLK1/CDK2",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/38","41/2914",0.0988510759471876,0.187918257005404,0.106894822561895,"SRC/STAT1",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/38","87/2914",0.102663943915541,0.194413916965224,0.110589793076694,"MAPK3/MAPK1/TRAF6",3
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/38","42/2914",0.10296607810546,0.194413916965224,0.110589793076694,"PLK1/PRKACA",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","2/38","44/2914",0.111336806866634,0.20950878859701,0.119176311759803,"SRC/AKT1",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/38","46/2914",0.119882980017397,0.218952871261055,0.124548453651285,"AR/ESR1",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/38","46/2914",0.119882980017397,0.218952871261055,0.124548453651285,"SUMO1/PARP1",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/38","46/2914",0.119882980017397,0.218952871261055,0.124548453651285,"SUMO1/BRCA1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"MAPK3",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"RB1",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"PRKCH",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"BRCA1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"SRC",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"TRAF6",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"CREB1",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"EP300",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"AKT1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"SRC",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"STAT1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"STAT1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/38","10/2914",0.123191937751796,0.218952871261055,0.124548453651285,"EP300",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/38","47/2914",0.12421742786085,0.218952871261055,0.124548453651285,"SRC/PLK1",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","2/38","47/2914",0.12421742786085,0.218952871261055,0.124548453651285,"SUMO1/STAT1",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","2/38","47/2914",0.12421742786085,0.218952871261055,0.124548453651285,"AKT1/CDK2",2
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","2/38","47/2914",0.12421742786085,0.218952871261055,0.124548453651285,"AKT1/CDK2",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/38","48/2914",0.128590493379316,0.22257740079511,0.126610219482808,"MAPK14/TRAF6",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/38","97/2914",0.130881100762956,0.22257740079511,0.126610219482808,"MAPK3/SUMO1/STAT1",3
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/38","49/2914",0.13300050377284,0.22257740079511,0.126610219482808,"SRC/STAT1",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"STAT1",1
"R-HSA-110373","R-HSA-110373","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"PARP1",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"RB1",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"AKT1",1
"R-HSA-163615","R-HSA-163615","PKA activation","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"PRKACA",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"TRAF6",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"TRAF6",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"AKT1",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"SRC",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"EP300",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"ROCK2",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"SRC",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"ROCK2",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"CDK2",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"ESR1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"PRKAA2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"STAT1",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/38","11/2914",0.134665321486449,0.22257740079511,0.126610219482808,"AKT1",1
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"CREB1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"SMAD3",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"STAT1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"YAP1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"NOTCH1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"CTNNB1",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"CDK2",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"PRKACA",1
"R-HSA-937039","R-HSA-937039","IRAK1 recruits IKK complex","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"TRAF6",1
"R-HSA-975110","R-HSA-975110","TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"TRAF6",1
"R-HSA-975144","R-HSA-975144","IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"TRAF6",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/38","12/2914",0.145992471945806,0.230409181515097,0.131065224673616,"TRAF6",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","2/38","52/2914",0.146435996869559,0.230409181515097,0.131065224673616,"CREB1/EP300",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/38","52/2914",0.146435996869559,0.230409181515097,0.131065224673616,"MAPK3/MAPK1",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/38","52/2914",0.146435996869559,0.230409181515097,0.131065224673616,"MAPK3/MAPK1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/38","53/2914",0.150977748915223,0.234081786566708,0.133154337629366,"SRC/PRKAA2",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","2/38","53/2914",0.150977748915223,0.234081786566708,0.133154337629366,"SRC/AKT1",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/38","53/2914",0.150977748915223,0.234081786566708,0.133154337629366,"SRC/TRAF6",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"EP300",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"TRAF6",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AKT1",1
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"TRAF6",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"SRC",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"SRC",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"NOTCH1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AMER1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"EP300",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"AKT1",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"TRAF6",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/38","13/2914",0.157175203188418,0.234081786566708,0.133154337629366,"EP300",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/38","55/2914",0.160147061573925,0.237871768791136,0.135310219042109,"PRKACA/PRKAA2",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/38","56/2914",0.164771710215372,0.243999807849791,0.138796073254818,"PLK1/PRKACA",2
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","4/38","165/2914",0.165165299631446,0.243999807849791,0.138796073254818,"MAPK3/CREB1/MAPK1/PRKCH",4
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","3/38","109/2914",0.16794718367086,0.243999807849791,0.138796073254818,"EP300/KDM6A/HDAC1",3
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","3/38","109/2914",0.16794718367086,0.243999807849791,0.138796073254818,"EP300/KDM6A/HDAC1",3
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/38","14/2914",0.16821530738657,0.243999807849791,0.138796073254818,"CTNNB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/38","14/2914",0.16821530738657,0.243999807849791,0.138796073254818,"BRCA1",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/38","14/2914",0.16821530738657,0.243999807849791,0.138796073254818,"EP300",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/38","14/2914",0.16821530738657,0.243999807849791,0.138796073254818,"SMAD3",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/38","14/2914",0.16821530738657,0.243999807849791,0.138796073254818,"SRC",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/38","57/2914",0.169421131133402,0.245110571535857,0.139427916530838,"CTNNB1/SRC",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"AKT1",1
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"SMAD3",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"SRC",1
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"PTPN13",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"PLK1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"YAP1",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"KDM6A",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"AR",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"PRKACA",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"ROCK2",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"HDAC1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"MAPK14",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"BRCA1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/38","15/2914",0.179114555082884,0.249417017952917,0.141877581789337,"AKT1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/38","61/2914",0.18823940984378,0.258582409198786,0.147091193742483,"SRC/PRKAA2",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"CDK2",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"HDAC1",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"AKT1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"SRC",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"SRC",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"PARP1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"PLK1",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/38","16/2914",0.189874695443992,0.258582409198786,0.147091193742483,"SRC",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","8/38","436/2914",0.198145164786295,0.267810751263327,0.152340614438744,"MAPK3/CREB1/SRC/MAPK1/AKT1/ROCK2/PRKACA/PRKCH",8
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"PRKACA",1
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"TRAF6",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"SRC",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"SUMO1",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"HDAC1",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"PARP1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/38","17/2914",0.200497456511324,0.267810751263327,0.152340614438744,"CDK2",1
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"PTPN13",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"PRKAA2",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"PRKACA",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"PRKACA",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"EP300",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/38","18/2914",0.210984545449042,0.277821257246138,0.158034958766111,"BRCA1",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"PLK1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"CTNNB1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"SRC",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"PRKACA",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"HDAC1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/38","19/2914",0.221337648789145,0.286675623452981,0.163071648227057,"EP300",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/38","68/2914",0.221826200553384,0.286675623452981,0.163071648227057,"SRC/ROCK2",2
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/38","20/2914",0.231558432673777,0.295821208713977,0.168273993806873,"TRAF6",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/38","20/2914",0.231558432673777,0.295821208713977,0.168273993806873,"PRKACA",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/38","20/2914",0.231558432673777,0.295821208713977,0.168273993806873,"PRKACA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/38","20/2914",0.231558432673777,0.295821208713977,0.168273993806873,"PRKACA",1
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","1/38","20/2914",0.231558432673777,0.295821208713977,0.168273993806873,"TRAF6",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/38","72/2914",0.241265839134584,0.303149185819359,0.17244241695479,"SRC/ESR1",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"NOTCH1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"AKT1",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"AKT1",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"SUMO1",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"PARP1",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/38","21/2914",0.241648543094785,0.303149185819359,0.17244241695479,"TRAF6",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"PRKACA",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"CDK2",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"SMAD3",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"PRKACA",1
"R-HSA-5696400","R-HSA-5696400","Dual Incision in GG-NER","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"PARP1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"CDK2",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"CDK2",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/38","22/2914",0.251609606130526,0.309374283917666,0.175983481922362,"EP300",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/38","76/2914",0.260802507033748,0.318651812026811,0.181260881451517,"TRAF6/HDAC1",2
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/38","23/2914",0.261443228179987,0.318651812026811,0.181260881451517,"BRCA1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/38","23/2914",0.261443228179987,0.318651812026811,0.181260881451517,"STAT1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/38","23/2914",0.261443228179987,0.318651812026811,0.181260881451517,"CDK2",1
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","4/38","202/2914",0.267773309656605,0.324101083433869,0.18436062763601,"MAPK3/SRC/MAPK1/PRKACA",4
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"EP300",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"STAT1",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"AR",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"BRCA1",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"CDK2",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"STAT1",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"AKT1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/38","24/2914",0.271150996194224,0.324101083433869,0.18436062763601,"STAT1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/38","25/2914",0.280734477905165,0.333409603823405,0.189655656715194,"AKT1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/38","25/2914",0.280734477905165,0.333409603823405,0.189655656715194,"SRC",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/38","25/2914",0.280734477905165,0.333409603823405,0.189655656715194,"AKT1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/38","144/2914",0.289075832146269,0.342454954836542,0.194800985364829,"SRC/AKT1/PRKAA2",3
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/38","26/2914",0.290195222051791,0.342454954836542,0.194800985364829,"CTNNB1",1
"R-HSA-936440","R-HSA-936440","Negative regulators of DDX58/IFIH1 signaling","1/38","26/2914",0.290195222051791,0.342454954836542,0.194800985364829,"NLRX1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","8/38","486/2914",0.293277395923505,0.345360485262986,0.196453758034884,"MAPK3/CREB1/SRC/MAPK1/AKT1/ROCK2/PRKACA/PRKCH",8
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/38","27/2914",0.299534758603741,0.349771196105417,0.1989627327369,"NOTCH1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/38","27/2914",0.299534758603741,0.349771196105417,0.1989627327369,"TRAF6",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/38","27/2914",0.299534758603741,0.349771196105417,0.1989627327369,"CDK2",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/38","27/2914",0.299534758603741,0.349771196105417,0.1989627327369,"SRC",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/38","28/2914",0.308754598982355,0.357539109424474,0.20338140779886,"PLK1",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/38","28/2914",0.308754598982355,0.357539109424474,0.20338140779886,"SMAD3",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/38","28/2914",0.308754598982355,0.357539109424474,0.20338140779886,"PRKACA",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/38","28/2914",0.308754598982355,0.357539109424474,0.20338140779886,"EP300",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/38","217/2914",0.312705835703589,0.361363382752903,0.205556795253943,"CREB1/SRC/MAPK1/PRKACA",4
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/38","29/2914",0.317856236279192,0.363543990980513,0.206797205490191,"AKT1",1
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/38","29/2914",0.317856236279192,0.363543990980513,0.206797205490191,"PLK1",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/38","29/2914",0.317856236279192,0.363543990980513,0.206797205490191,"PLK1",1
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","1/38","29/2914",0.317856236279192,0.363543990980513,0.206797205490191,"PRKCH",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/38","29/2914",0.317856236279192,0.363543990980513,0.206797205490191,"SRC",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/38","289/2914",0.323039610213081,0.368715292804684,0.209738832342833,"AKT1/EP300/PRKACA/PRKAA2/PTPN13",5
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/38","30/2914",0.326841145472049,0.371531669444757,0.211340891057114,"PTPN13",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/38","30/2914",0.326841145472049,0.371531669444757,0.211340891057114,"PLK1",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/38","31/2914",0.335710783638505,0.379291899567236,0.215755195634013,"PRKACA",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/38","31/2914",0.335710783638505,0.379291899567236,0.215755195634013,"AKT1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/38","31/2914",0.335710783638505,0.379291899567236,0.215755195634013,"STAT1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/38","296/2914",0.341808168410008,0.385399088672823,0.219229189625852,"SRC/FBXO22/AKT1/TRAF6/PRKACA",5
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/38","32/2914",0.34446659016703,0.386052094010132,0.219600643101294,"CREB1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/38","32/2914",0.34446659016703,0.386052094010132,0.219600643101294,"STAT1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/38","32/2914",0.34446659016703,0.386052094010132,0.219600643101294,"EP300",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/38","160/2914",0.347371293214828,0.38852572353546,0.221007734638899,"SRC/AKT1/PRKAA2",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","2/38","94/2914",0.348457936221859,0.388960061073298,0.221254801820018,"AKT1/STAT1",2
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/38","33/2914",0.353109986965661,0.391797336135205,0.222868748325988,"BRCA1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/38","33/2914",0.353109986965661,0.391797336135205,0.222868748325988,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/38","33/2914",0.353109986965661,0.391797336135205,0.222868748325988,"CDK2",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/38","34/2914",0.3616423786683,0.398092499838425,0.226449669189012,"PLK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/38","34/2914",0.3616423786683,0.398092499838425,0.226449669189012,"EP300",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/38","34/2914",0.3616423786683,0.398092499838425,0.226449669189012,"PRKACA",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/38","34/2914",0.3616423786683,0.398092499838425,0.226449669189012,"BRCA1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/38","35/2914",0.370065152838649,0.404963241907913,0.230358000215972,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/38","35/2914",0.370065152838649,0.404963241907913,0.230358000215972,"PRKACA",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/38","35/2914",0.370065152838649,0.404963241907913,0.230358000215972,"PRKACA",1
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/38","36/2914",0.378379680171796,0.413249964422923,0.235071793047907,"SRC",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/38","171/2914",0.387419844223575,0.422295211805345,0.240217062748575,"MAPK3/SRC/MAPK1",3
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/38","38/2914",0.394689393957197,0.428541895583155,0.243770406445299,"TRAF6",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/38","38/2914",0.394689393957197,0.428541895583155,0.243770406445299,"ROCK2",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/38","39/2914",0.402687239238708,0.43637508221004,0.248226211367707,"EP300",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/38","106/2914",0.405289487149178,0.43834222202348,0.2493451929114,"TRAF6/HDAC1",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","3/38","177/2914",0.409089281074563,0.441494711855068,0.251138445182605,"MAPK3/SRC/MAPK1",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/38","40/2914",0.41058215572877,0.441494711855068,0.251138445182605,"EP300",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/38","40/2914",0.41058215572877,0.441494711855068,0.251138445182605,"CTNNB1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/38","41/2914",0.41837543272331,0.448993193898431,0.255403857816173,"STAT1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/38","109/2914",0.419167793226543,0.448993193898431,0.255403857816173,"MAPK14/AKT1",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/38","42/2914",0.42606834381155,0.452038223815302,0.257135982931883,"CTNNB1",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/38","42/2914",0.42606834381155,0.452038223815302,0.257135982931883,"SRC",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/38","42/2914",0.42606834381155,0.452038223815302,0.257135982931883,"MAPK14",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/38","42/2914",0.42606834381155,0.452038223815302,0.257135982931883,"PLK1",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/38","42/2914",0.42606834381155,0.452038223815302,0.257135982931883,"STAT1",1
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/38","43/2914",0.433662147061954,0.459220182345073,0.2612213453385,"TRAF6",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/38","44/2914",0.441158085206032,0.464508607674404,0.264229596352633,"SRC",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/38","44/2914",0.441158085206032,0.464508607674404,0.264229596352633,"CDK2",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/38","44/2914",0.441158085206032,0.464508607674404,0.264229596352633,"PRKACA",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/38","188/2914",0.448275009310436,0.468755091748135,0.266645152822808,"MAPK3/SRC/MAPK1",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/38","45/2914",0.448557385820029,0.468755091748135,0.266645152822808,"STAT1",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/38","45/2914",0.448557385820029,0.468755091748135,0.266645152822808,"PRKACA",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/38","45/2914",0.448557385820029,0.468755091748135,0.266645152822808,"PRKACA",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/38","47/2914",0.463070910062003,0.483015911806246,0.274757232266238,"EP300",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/38","48/2914",0.470187514672273,0.489522328359731,0.278458321527504,"EP300",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/38","50/2914",0.4841462526962,0.503114669313029,0.28619014544689,"MEN1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/38","125/2914",0.490397032884088,0.50738740123479,0.288620632659306,"MAPK14/MAPK1",2
"R-HSA-69306","R-HSA-69306","DNA Replication","1/38","51/2914",0.490990680907633,0.50738740123479,0.288620632659306,"CDK2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/38","51/2914",0.490990680907633,0.50738740123479,0.288620632659306,"FBXO22",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/38","126/2914",0.494677603910522,0.510250787737335,0.290249432313971,"CTNNB1/SRC",2
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/38","53/2914",0.50441528791579,0.519333300127717,0.295415899723033,"PRKACA",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/38","55/2914",0.517494912003586,0.531816726911435,0.302516932439463,"PRKACA",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/38","56/2914",0.523908061127008,0.537415819609104,0.305701902489541,"PLK1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/38","57/2914",0.530238184876894,0.542909317971379,0.308826806594321,"TRAF6",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/38","59/2914",0.542653528123382,0.554601862687567,0.315477956475399,"TRAF6",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/38","60/2914",0.548740801654489,0.559796019270239,0.318432583956047,"PLK1",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/38","61/2914",0.554749158184668,0.561809602016109,0.319577983949445,"TRAF6",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/38","61/2914",0.554749158184668,0.561809602016109,0.319577983949445,"PLK1",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/38","61/2914",0.554749158184668,0.561809602016109,0.319577983949445,"MEN1",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/38","61/2914",0.554749158184668,0.561809602016109,0.319577983949445,"ROCK2",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/38","62/2914",0.560679593512037,0.566784997434128,0.322408172026216,"SRC",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/38","69/2914",0.600091964230675,0.605527579848707,0.344446379163679,"SRC",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/38","73/2914",0.621044435008766,0.62553661898713,0.355828257233537,"SRC",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/38","76/2914",0.636053405203292,0.639497737722443,0.363769855531429,"CTNNB1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/38","88/2914",0.69050908900538,0.692997410046841,0.394202438673531,"FBXO22",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/38","115/2914",0.785629731072355,0.787042734185794,0.447698881205564,"FBXO22",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/38","121/2914",0.802524361335078,0.802524361335078,0.45650540066495,"PRKACA",1
